Before moving country, prepare a concise clinical summary, check travel and dispensing rules separately, and identify who will provide local follow-up. An EU cross-border prescription does not guarantee availability or dispensing of every medicine, and controlled medicines may have additional restrictions.
A move changes the care setting
Your diagnosis and history do not disappear at the border. What changes is who can provide follow-up, which preparations are available, how prescriptions work and what a university or employer may require. Continuity should therefore be planned as a separate task rather than left until the final supply of medicine is nearly finished.
If you are seeking a first assessment rather than transferring established care, start with the information for Greek-speaking adults abroad. Remote appointment suitability, recognition of a report and local prescribing are separate questions.
Prepare a one-page clinical summary
A short, accurate summary is often more useful than an unstructured bundle of documents. Ask your current clinician what can appropriately be provided. Useful fields include:
- the diagnosis and how and when it was established;
- the generic name, formulation, strength and current dose of each medicine;
- previous options tried and why they changed;
- benefits and adverse effects being monitored;
- recent relevant measurements or tests, where applicable;
- what the next clinician needs to continue and when.
A summary is not automatically a prescription, an import permit or a guarantee that a new clinician will continue the same plan. It gives the receiving clinician a clear starting point for a safe decision.
Medicines require three separate checks
| Question | Where to check | What to confirm |
|---|---|---|
| Can I cross the border with it? | Embassy, customs or medicines authority for the destination and any transit country | Quantity limits, original packaging, clinician letter and any permit |
| Can the prescription be dispensed? | Local pharmacist and national rules | Availability, accepted prescription format and time or quantity limits |
| Who will monitor treatment? | Local clinician or ADHD service | Acceptance of previous assessment, required checks and next appointment |
The European Union’s official portal explains that an EU prescription can be used in another EU country, but the medicine may not be available and dispensing follows the destination country’s rules. A paper copy may be needed for an electronic prescription. This general framework does not remove additional controls that may apply to controlled medicines.
The INCB collates country-submitted information for travellers carrying controlled medicines. Information may be incomplete or outdated for some countries, so confirm it directly with the relevant authority. Do not mail medicines or change a dose because of an administrative obstacle without speaking to the clinician responsible for your care.
A realistic transition timeline
Several weeks before moving: record the exact medicine and active ingredient, request the summary, check destination rules and begin looking for a local service. Waiting times and entry requirements vary.
Before travel: keep the required documents with medicines in original packaging where the rules for your route permit this. Confirm whether a letter must state travel dates, quantity, dose and the prescriber’s signature. The United Kingdom, for example, publishes specific requirements for medicines containing controlled drugs; these should not be generalised to other countries.
During the first days after arrival: complete local health-system or insurance registration, identify a pharmacy and arrange follow-up before a gap develops. A simple record of symptoms, sleep and possible adverse effects can support the first discussion with the receiving clinician.
Monitoring and treatment changes
NICE guidance emphasises continuity of care, a shared treatment plan and regular monitoring of effectiveness and adverse effects. Adults taking ADHD medication may need monitoring of weight, pulse, blood pressure, sleep and other parameters according to the medicine and individual history.
Moving is not, by itself, a reason to stop, increase or reduce treatment. If the same brand is unavailable, the receiving clinician needs the generic name, formulation and response history to consider locally available options. Read more about adult ADHD treatment and monitoring.
Education, work and documents follow different rules
A university, employer, insurer and local clinician may each request different information. Ask in writing who can issue acceptable documentation, the required language, how recent it must be and whether a local assessment is needed. An English translation may aid understanding, but it does not guarantee administrative acceptance.
For education, read the guide to ADHD at university. For practical workplace approaches, see ADHD at work. Disclosure of a diagnosis is a personal decision, and protections and adjustment processes vary by country.
Frequently asked questions
Is a Greek prescription valid throughout the European Union?
There is an EU framework for cross-border prescriptions, but availability and dispensing follow the rules of the country where you present it. Controlled medicines may be subject to additional restrictions.
Can I travel with stimulant ADHD medication?
It depends on the active ingredient, quantity, destination and transit countries. Check the relevant authorities early and carry the required evidence. Do not apply one country’s rule to another.
Is an English report enough to continue medication?
It can help the receiving clinician understand the history, but it does not require them to accept the diagnosis or prescribe the same medicine. A local assessment or additional monitoring may be required.
When should I start planning?
As soon as the move is known. Waiting times, travel permits and health-system registration vary, so allowing several weeks is safer than leaving arrangements until the final supply.
Sources & further reading
- NICE · Attention deficit hyperactivity disorder: diagnosis and management (NG87)
- Your Europe · Presenting a prescription in another EU country
- INCB · Country regulations for travellers carrying controlled medicines
- GOV.UK · Take medicine in or out of the UK
Educational information. It does not replace individual clinical assessment. About this content